Objective: The objective of this study is to evaluate the ability of silver oxide nanoparticle (Ag2ONP)-functionalized high-efficiency particulate air (HEPA) filters and colloidal Ag2ONP suspensions to inhibit biofilm formation by major respiratory pathogens causing infections at operating rooms. Background: Respiratory infections caused by bacterial pathogens such as Streptococcus pneumoniae, Pseudomonas aeruginosa and Staphylococcus species are often associated with the formation of biofilms, which confer increased resistance to antibiotics and host immune responses. Effective strategies to prevent biofilm formation on biological surfaces and in air filtration systems are urgently needed in clinical settings. Methods: The biofilm-forming ability of each bacterial strain was assessed by crystal violet microplate assay, viable count or confocal microscopy after prior incubation of the culture medium with Ag2ONP-coated HEPA filter material or colloidal Ag2ONP suspension. Results: Both silver-functionalized filters and silver nanoparticle suspensions significantly inhibited biofilm formation by S. pneumoniae and P. aeruginosa, with near-complete suppression observed. In the case of S. aureus and S. epidermidis, the silver nanoparticle suspension showed partial inhibition of biofilm development. Conclusions: Ag2ONP-functionalized HEPA filters and colloidal Ag2ONP suspensions effectively prevent biofilm formation by major respiratory pathogens, for both Gram-negative and Gram-positive bacteria. These materials show promise for integration with air filtration and surface coating systems to reduce microbial load and transmission in healthcare environments such as operating room facilities.
Antimicrobial resistance and the formation of biofilms in Gram-positive pathogens such as Streptococcus pneumoniae and Staphylococcus aureus are making the treatment of infections increasingly difficult. This study systematically evaluates the effect of gliotoxin (GT), an antimicrobial metabolite produced by Aspergillus fumigatus, on bacterial growth and biofilm formation, as well as its activity in combination with antibiotics. Three strains of S. pneumoniae and two strains of S. aureus (one methicillin-susceptible and one methicillin-resistant) were analysed. Planktonic growth was examined, and biofilm prevention assays were conducted by assessing biomass via crystal violet staining and viable cell counts. In addition, the combined effect of GT with cefotaxime and vancomycin was evaluated. GT inhibited planktonic growth and significantly reduced the biomass and viability of biofilms in a concentration-dependent manner. Moreover, its combination with conventional antibiotics (cefotaxime or vancomycin) showed strong synergy, drastically decreasing bacterial survival. These findings highlight the potent antibacterial and anti-biofilm activity of GT and its ability to enhance antibiotic efficacy, providing insight into fungal–bacterial interactions and suggesting potential therapeutic applications.